Join the Tyruko group to help and get support from people like you.
Tyruko News
Adverse Outcomes Seen With MS Disease-Modifying Drugs in Pregnancy
THURSDAY, Jan. 2, 2025 – Disease-modifying therapy (DMT) use for multiple sclerosis (MS) in pregnancy is associated with certain adverse outcomes, including small for gestational age, according to a...
FDA Approves Tyruko (natalizumab-sztn), a Biosimilar to Tysabri
August 24, 2023 – The U.S. Food and Drug Administration today approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing...
Further information
Related condition support groups
Multiple Sclerosis, Crohn's Disease - Maintenance